These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 14734477)

  • 1. Effective intravenous therapy of murine pulmonary metastases with an oncolytic herpes virus expressing interleukin 12.
    Wong RJ; Chan MK; Yu Z; Kim TH; Bhargava A; Stiles BM; Horsburgh BC; Shah JP; Ghossein RA; Singh B; Fong Y
    Clin Cancer Res; 2004 Jan; 10(1 Pt 1):251-259. PubMed ID: 14734477
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angiogenesis inhibition by an oncolytic herpes virus expressing interleukin 12.
    Wong RJ; Chan MK; Yu Z; Ghossein RA; Ngai I; Adusumilli PS; Stiles BM; Shah JP; Singh B; Fong Y
    Clin Cancer Res; 2004 Jul; 10(13):4509-16. PubMed ID: 15240543
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytokine gene transfer enhances herpes oncolytic therapy in murine squamous cell carcinoma.
    Wong RJ; Patel SG; Kim S; DeMatteo RP; Malhotra S; Bennett JJ; St-Louis M; Shah JP; Johnson PA; Fong Y
    Hum Gene Ther; 2001 Feb; 12(3):253-65. PubMed ID: 11177562
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interleukin 12 secretion enhances antitumor efficacy of oncolytic herpes simplex viral therapy for colorectal cancer.
    Bennett JJ; Malhotra S; Wong RJ; Delman K; Zager J; St-Louis M; Johnson P; Fong Y
    Ann Surg; 2001 Jun; 233(6):819-26. PubMed ID: 11371740
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neoadjuvant treatment of hepatic malignancy: an oncolytic herpes simplex virus expressing IL-12 effectively treats the parent tumor and protects against recurrence-after resection.
    Jarnagin WR; Zager JS; Klimstra D; Delman KA; Malhotra S; Ebright M; Little S; DeRubertis B; Stanziale SF; Hezel M; Federoff H; Fong Y
    Cancer Gene Ther; 2003 Mar; 10(3):215-23. PubMed ID: 12637943
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systemic oncolytic herpes virus therapy of poorly immunogenic prostate cancer metastatic to lung.
    Varghese S; Rabkin SD; Nielsen PG; Wang W; Martuza RL
    Clin Cancer Res; 2006 May; 12(9):2919-27. PubMed ID: 16675589
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced therapeutic efficacy of IL-12, but not GM-CSF, expressing oncolytic herpes simplex virus for transgenic mouse derived prostate cancers.
    Varghese S; Rabkin SD; Liu R; Nielsen PG; Ipe T; Martuza RL
    Cancer Gene Ther; 2006 Mar; 13(3):253-65. PubMed ID: 16179929
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oncolytic herpesvirus effectively treats murine squamous cell carcinoma and spreads by natural lymphatics to treat sites of lymphatic metastases.
    Wong RJ; Joe JK; Kim SH; Shah JP; Horsburgh B; Fong Y
    Hum Gene Ther; 2002 Jul; 13(10):1213-23. PubMed ID: 12133274
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination of vinblastine and oncolytic herpes simplex virus vector expressing IL-12 therapy increases antitumor and antiangiogenic effects in prostate cancer models.
    Passer BJ; Cheema T; Wu S; Wu CL; Rabkin SD; Martuza RL
    Cancer Gene Ther; 2013 Jan; 20(1):17-24. PubMed ID: 23138870
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Calcium depletion enhances nectin-1 expression and herpes oncolytic therapy of squamous cell carcinoma.
    Yu Z; Li S; Huang YY; Fong Y; Wong RJ
    Cancer Gene Ther; 2007 Aug; 14(8):738-47. PubMed ID: 17525764
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systemic therapy of spontaneous prostate cancer in transgenic mice with oncolytic herpes simplex viruses.
    Varghese S; Rabkin SD; Nielsen GP; MacGarvey U; Liu R; Martuza RL
    Cancer Res; 2007 Oct; 67(19):9371-9. PubMed ID: 17909046
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination vascular delivery of herpes simplex oncolytic viruses and amplicon mediated cytokine gene transfer is effective therapy for experimental liver cancer.
    Zager JS; Delman KA; Malhotra S; Ebright MI; Bennett JJ; Kates T; Halterman M; Federoff H; Fong Y
    Mol Med; 2001 Aug; 7(8):561-8. PubMed ID: 11591892
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sensitivity of squamous cell carcinoma lymph node metastases to herpes oncolytic therapy.
    Yu Z; Li S; Huang YY; Lin SF; Fong Y; Wong RJ
    Clin Cancer Res; 2008 Mar; 14(6):1897-904. PubMed ID: 18347193
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IL-12 Expressing oncolytic herpes simplex virus promotes anti-tumor activity and immunologic control of metastatic ovarian cancer in mice.
    Thomas ED; Meza-Perez S; Bevis KS; Randall TD; Gillespie GY; Langford C; Alvarez RD
    J Ovarian Res; 2016 Oct; 9(1):70. PubMed ID: 27784340
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interleukin-12 expression enhances vesicular stomatitis virus oncolytic therapy in murine squamous cell carcinoma.
    Shin EJ; Wanna GB; Choi B; Aguila D; Ebert O; Genden EM; Woo SL
    Laryngoscope; 2007 Feb; 117(2):210-4. PubMed ID: 17204993
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced antitumor effect of oncolytic adenovirus expressing interleukin-12 and B7-1 in an immunocompetent murine model.
    Lee YS; Kim JH; Choi KJ; Choi IK; Kim H; Cho S; Cho BC; Yun CO
    Clin Cancer Res; 2006 Oct; 12(19):5859-68. PubMed ID: 17020994
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nectin-1 expression by squamous cell carcinoma is a predictor of herpes oncolytic sensitivity.
    Yu Z; Adusumilli PS; Eisenberg DP; Darr E; Ghossein RA; Li S; Liu S; Singh B; Shah JP; Fong Y; Wong RJ
    Mol Ther; 2007 Jan; 15(1):103-13. PubMed ID: 17164781
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytokine-secreting herpes viral mutants effectively treat tumor in a murine metastatic colorectal liver model by oncolytic and T-cell-dependent mechanisms.
    Derubertis BG; Stiles BM; Bhargava A; Gusani NJ; Hezel M; D'Angelica M; Fong Y
    Cancer Gene Ther; 2007 Jun; 14(6):590-7. PubMed ID: 17431402
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intratumoral expression of interleukin 23 variants using oncolytic vaccinia virus elicit potent antitumor effects on multiple tumor models via tumor microenvironment modulation.
    Chen L; Chen H; Ye J; Ge Y; Wang H; Dai E; Ren J; Liu W; Ma C; Ju S; Guo ZS; Liu Z; Bartlett DL
    Theranostics; 2021; 11(14):6668-6681. PubMed ID: 34093846
    [No Abstract]   [Full Text] [Related]  

  • 20. Engineered herpes simplex virus expressing IL-12 in the treatment of experimental murine brain tumors.
    Parker JN; Gillespie GY; Love CE; Randall S; Whitley RJ; Markert JM
    Proc Natl Acad Sci U S A; 2000 Feb; 97(5):2208-13. PubMed ID: 10681459
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.